MétaCan
Menu
Back to cohort

Abstract A037: Survival-based subtyping of lung cancer through integrated genomic and methylation signatures

2025· article· en· W4412163749 on OpenAlexaboutno aff
Aaron Hardin, Sheila Solomon, Amar K. Das

Bibliographic record

VenueClinical Cancer Research · 2025
Typearticle
Languageen
FieldMedicine
TopicFerroptosis and cancer prognosis
Canadian institutionsnot available
Fundersnot available
KeywordsSubtypingLung cancerMethylationDNA methylationCancerBiologyComputational biologyMedicineCancer researchOncologyGeneticsGeneGene expressionComputer science

Abstract

fetched live from OpenAlex

Abstract Background: Lung cancer prognosis varies significantly due to the interplay of clinical, genomic and epigenomic factors. We developed an integrative analytic pipeline to cluster lung cancer patients based on clinical characteristics, somatic mutations, and methylation profiles, linking these clusters to survival outcomes. Methods: We defined a cohort using clinical data from GuardantINFORM, a clinico-genomics database to identify 75,000 lines of therapy (LOT) records of advanced lung cancer patients with a Guardant360 on the Infinity platform resulting in genomic mutation data (3M variants) and targeted methylation data (top 1,000 variable regions) and used to predict clusters of progression on the following line of therapy . Features included clinical factors (LOT, therapy regimens), binary mutation indicators (top-100 genes), and 20 principal components (PCs) derived from methylation data. Ensemble clustering using K-means and agglomerative methods identified patient subgroups. Survival was analyzed via Kaplan–Meier methods, and a penalized Cox proportional hazards model determined feature-level hazard ratios. Results: Four robust clusters emerged with distinct survival profiles (p<0.0001). Cox modeling (concordance=0.72) highlighted several prognostic markers: KRAS mutations (HR=1.24, p=0.01), STK11 mutations (HR=1.49, p<0.005), KEAP1 mutations (HR=1.33, p=0.01), and methylation PC5 (HR=0.03, p=0.01). Biological interpretation of PC5 revealed enrichment of hypermethylation in key developmental genes such as PAX6, SOX9, OTX2, WT1, and TBX20. This suggests epigenetic suppression of differentiation-related transcription factors may contribute significantly to tumor aggressiveness. Conclusions: Integrating clinical, genetic, and methylation data via ensemble clustering effectively delineates lung cancer subgroups with clinically meaningful survival differences. Key mutations in KRAS, STK11, and KEAP1 and methylation-driven silencing of developmental transcription factors represent robust markers for patient risk stratification and potential therapeutic targeting Citation Format: Aaron Hardin, Sheila Solomon, Amar Das. Survival-based subtyping of lung cancer through integrated genomic and methylation signatures [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning; 2025 Jul 10-12; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(13_Suppl):Abstract nr A037.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.202
GPT teacher head0.545
Teacher spread0.343 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueClinical Cancer ResearchSame topicFerroptosis and cancer prognosisFrench-language works237,207